Recognition and screening for Chagas disease in the USA

Rachel Marcus, Andrés F. Henao-Martínez, Melissa Nolan, Elizabeth Livingston, Stephen A. Klotz, Robert H. Gilman, Monica Miranda-Schaeubinger, Sheba Meymandi

Research output: Contribution to journalReview articlepeer-review


Chagas disease (CD), caused by the protozoan Trypanosoma cruzi, is a public health concern, mainly among countries in South and Central America. However, despite the large number of immigrants from endemic countries living in the USA, awareness of CD is poor in the medical community, and therefore it is significantly underdiagnosed. To avoid the catastrophic cardiac complications of CD and to prevent maternal–fetal transmission, widespread educational programs highlighting the need for diagnosis are urgently needed.

Original languageEnglish (US)
JournalTherapeutic Advances in Infectious Disease
StatePublished - 2021


  • Chagas disease
  • Trypanosoma cruzi
  • USA
  • congenital Chagas
  • screening

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'Recognition and screening for Chagas disease in the USA'. Together they form a unique fingerprint.

Cite this